Predicting the Response to Montelukast by Genetic Variation in Asthmatics

NCT00116324 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Asthma

Interventions

DRUG: Montelukast

Sponsor

Brigham and Women's Hospital

Collaborators

[object Object]